
Kite Pharma
North America, California, United States, Los Angeles
Description
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.
Investor Profile
Kite Pharma has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 17% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands, China.
- Strong thematic focus on Biotechnology, Therapeutics, Pharmaceutical.
Stage Focus
- Post Ipo Equity (25%)
- Series A (17%)
- Series B (17%)
- Series C (17%)
- Corporate Round (17%)
- Series Unknown (8%)
Country Focus
- United States (75%)
- The Netherlands (8%)
- China (8%)
- France (8%)
Industry Focus
- Biotechnology
- Therapeutics
- Pharmaceutical
- Health Care
- Medical
- Life Science
- Biopharma
- Genetics
- Oncology
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Kite Pharma frequently co-invest with?
What are some of recent deals done by Kite Pharma?
Find More Investors Like Kite Pharma
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








